Cas:20156-50-7 dichloromethylsilane manufacturer & supplier

We serve Chemical Name:dichloromethylsilane CAS:20156-50-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

dichloromethylsilane

Chemical Name:dichloromethylsilane
CAS.NO:20156-50-7
Synonyms:chloro-chloromethyl-silane;2-chloroheptamethyltrisilane;Chlor-chlormethylsilan;Heptamethyl-2-chlortrisilan;Trisilane,2-chloro-1,1,1,2,3,3,3-heptamethyl;2-Chlorheptamethyltrisilan;chloromethylchlorosilane
Molecular Formula:CH4Cl2Si
Molecular Weight:115.03400
HS Code:2931900090

Physical and Chemical Properties:
Melting point:-93ºC(lit.)
Boiling point:41ºC(lit.)
Density:1.105 g/mL at 25ºC(lit.)
Index of Refraction:n20/D 1.398(lit.)
PSA:
Exact Mass:113.94600
LogP:1.31430

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 1242 4.3/PG 1
Packing Group:


Contact us for information like chloro-chloromethyl-silane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,chloromethylchlorosilane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Trisilane,2-chloro-1,1,1,2,3,3,3-heptamethyl Use and application,2-Chlorheptamethyltrisilan technical grade,usp/ep/jp grade.


Related News: At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs. dichloromethylsilane manufacturer Later on Friday, Canada’s drug regulator said it would not release J&J’s shipment of 300,000 COVID-19 vaccine doses, which were made at the Baltimore plant. dichloromethylsilane supplier At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs. dichloromethylsilane vendor The Company��s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs). dichloromethylsilane factory Among them, Zhejiang pharmaceutical companies accounted for 4 of the world’s top ten API manufacturers.